Botox

1 / 1
FDA Approves BOTOX® (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
Botox

FDA Approves BOTOX® (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity

Nice Insight

PR-M06-19-NI-043Jun 24, 2019
U.S. FDA Approves Botox Competitor
FDA Approval

U.S. FDA Approves Botox Competitor

Nice Insight

PAO-M02-19-NI-005Feb 07, 2019
Allergan Makes Neurotoxin Buy with Acquisition of Bonti Inc.
Acquisition

Allergan Makes Neurotoxin Buy with Acquisition of Bonti Inc.

Emilie Branch

Pharma's Almanac

PAO-M09-18-NI-015Sep 19, 2018
1 / 1